Paxillin anticorps (AA 86-90)
Aperçu rapide pour Paxillin anticorps (AA 86-90) (ABIN5689332)
Antigène
Voir toutes Paxillin (PXN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 86-90
-
Specificité
- This antibody detects endogenous level of total Paxillin protein.
-
Purification
- Antibodies were purified by affinity-chromatography using epitope-specific peptide.
-
Immunogène
- Paxillin (Ab-88) antibody was raised against a peptide sequence around aa.86~90 (P-V-Y-G-S) derived from Human Paxillin.
-
-
-
-
Indications d'application
- Western Blot: 1:500~1:1000, Immunofluorescence: 1:50~1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store antibody at -20°C for up to one year.
-
-
- Paxillin (PXN)
-
Autre désignation
- Paxillin
-
Sujet
- Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion).
-
Poids moléculaire
- 68 kDa
-
ID gène
- 5829
-
NCBI Accession
- NP_001074324
-
UniProt
- P49023
-
Pathways
- Signalisation MAPK, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Antigène
-